Cannabidiol in humans-the quest for therapeutic targets. Zhornitsky S(1), Potvin S. Author information: (1)Multiple Sclerosis Clinic, Foothills. Cannabidiol (CBD), a major phytocannabinoid constituent of cannabis, is attracting growing attention in medicine for its anxiolytic, antipsychotic. Cannabidiol (CBD), a major phytocannabinoid constituent of cannabis, is attracting growing attention in medicine for its anxiolytic, antipsychotic, antiemetic and.
Quest Therapeutic in Targets Cannabidiol for Humans—The
The VFCF cannabis DNA sequencing program puts the pieces of the cannabis puzzle together for doctors, dispensaries, and patients, creating a verified genotype of common strains of cannabis with a structured educational program for Veterans and highly trained bud tenders cannabis sommeliers , that includes verification of strain by sight and smell. Veterans For Cannabis provides access to VFC Certified cannabis strains and also certified CBD oil that includes a dropper for dosing that has milliliters on the side of the dropper.
Physicians most often shy away from cannabis recommendations because they do not understand how to advise the patient and there is no dosing protocol. VFC has developed dosing schedules as well as a reliable, repeatable dosing option through our certified CBD oil. Now physicians can rest assured knowing the patient can accurately dose the CBD oil themselves.
With strain and outcome verification, comes legitimacy-and the ability for recommending physicians to confidently recommend treatment with cannabis to produce specific therapeutic results. Educational videos Please watch the below videos to learn more about the benefits of CBD therapy and cannbis therapy for PTSD and chronic pain as well as many other teratment options.
Done in collaboration with Potent LTD. DNA verification equals legitimacy-the right product with the right benefits for the right outcome and the same experience for the end user each time. Look for the VFCF certified logo at dispensaries that are a part of our program. This "Cited by" count includes citations to the following articles in Scholar. New articles by this author.
New citations to this author. New articles related to this author's research. Email address for updates. My profile My library Metrics Alerts. Yale School of Medicine. International Clinical Psychopharmacology 26 4 , , Journal of clinical psychopharmacology 30 4 , , Canadian journal of psychiatry.
Nonlinear dynamics, psychology, and life sciences 14 4 , , Multiple sclerosis and related disorders 5, , Progress in Neuro-Psychopharmacology and Biological Psychiatry 34 6 , , Articles 1—20 Show more. Cannabidiol in humans—the quest for therapeutic targets S Zhornitsky, S Potvin Pharmaceuticals 5 5 , , Oral versus long-acting injectable antipsychotics in the treatment of schizophrenia and special populations at risk for treatment nonadherence: Depression in multiple sclerosis: Multiple Sclerosis Journal 21 1 , ,
Cannabidiol in Humans-The Quest for Therapeutic Targets.
Cannabidiol in Humans—The Quest for Therapeutic Targets. Post navigation. ← Previous Cannabis Study · Next Cannabis Study →. CBD = Cannabidiol. Cannabidiol in Humans-The Quest for Therapeutic Targets. Zhornitsky S, Potvin S. Pharmaceuticals (Basel). ; 5(5) PMID: Abstract. in Humans—The Quest for Therapeutic Targets. By Josh Sosnow, DVM 26Nov 0 Comment. Cannabidiol in Humans—The Quest for Therapeutic Targets.